Measles-containing-vaccine first-dose (MCV1) immunization coverage in Sri Lanka
Sri Lanka: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 97.0% in 2025. ▬ Flat
Latest (2025)
97.0%
Change on year
down 2.0%
World rank
33rd
of 194 countries
All-time high
99.0%
in 2000
All-time low
96.0%
in 2004
Years of data
26
2000–2025
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Sri Lanka, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Sri Lanka recorded 97.0% for measles-containing-vaccine first-dose (mcv1) immunization coverage in 2025.
Compared with earlier readings it is down 2.0% on the previous year and down 2.0% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Sri Lanka peaked at 99.0% in 2000 and was at its lowest, 96.0%, in 2004.
That places Sri Lanka 33rd out of 194 countries with data for 2025, putting it in the top quarter.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Sri Lanka, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 99.0% | — |
| 2001 | 99.0% | +0.0% |
| 2002 | 99.0% | +0.0% |
| 2003 | 99.0% | +0.0% |
| 2004 | 96.0% | -3.0% |
| 2005 | 99.0% | +3.1% |
| 2006 | 99.0% | +0.0% |
| 2007 | 98.0% | -1.0% |
| 2008 | 98.0% | +0.0% |
| 2009 | 97.0% | -1.0% |
| 2010 | 99.0% | +2.1% |
| 2011 | 99.0% | +0.0% |
| 2012 | 99.0% | +0.0% |
| 2013 | 99.0% | +0.0% |
| 2014 | 99.0% | +0.0% |
| 2015 | 99.0% | +0.0% |
| 2016 | 99.0% | +0.0% |
| 2017 | 99.0% | +0.0% |
| 2018 | 99.0% | +0.0% |
| 2019 | 99.0% | +0.0% |
| 2020 | 96.0% | -3.0% |
| 2021 | 97.0% | +1.0% |
| 2022 | 99.0% | +2.1% |
| 2023 | 99.0% | +0.0% |
| 2024 | 99.0% | +0.0% |
| 2025 | 97.0% | -2.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 98.3% | 96.0% | 99.0% | 10 |
| 2010s | 99.0% | 99.0% | 99.0% | 10 |
| 2020s | 97.8% | 96.0% | 99.0% | 6 |
Countries ranked near Sri Lanka
More health data for Sri Lanka
- Un projection of annual infant deaths, annual growth rate -1.62 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7332 % change on previous year (2090)
- Heat deaths vs projected death rates 1,250 (2090)
- Un projection of annual infant deaths 304 (2100)
- Population ages 0-14, female, annual growth rate -2.27 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1064 units per person (2025)
- Population ages 0-14, male, annual growth rate -2.16 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1106 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Sri Lanka?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Sri Lanka was 97.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Sri Lanka?
- The highest recorded value was 99.0% in 2000.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Sri Lanka?
- The lowest recorded value was 96.0% in 2004.
- How does Sri Lanka rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Sri Lanka ranks 33rd out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Sri Lanka?
- Over the last ten years it is down 2.0%. The long-run trend across the full record is flat.
- Where does this Sri Lanka data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).